Cyclin D1 (CCND1) Mouse Monoclonal Antibody [Clone ID: OTI1G2]
CAT#: TA801655M
CCND1 mouse monoclonal antibody, clone OTI1G2 (formerly 1G2)
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 1350.00
货期*
                        现货
                    规格
                        Specifications
| Product Data | |
| Clone Name | OTI1G2 | 
| Applications | WB | 
| Recommend Dilution | WB 1:2000 | 
| Reactivity | Human, Mouse, Rat | 
| Host | Mouse | 
| Clonality | Monoclonal | 
| Immunogen | Full length human recombinant protein of human CCND1 (NP_444284) produced in E.coli. | 
| Isotype | IgG1 | 
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. | 
| Concentration | 1 mg/ml | 
| Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C as received. | 
| Gene Name | cyclin D1 | 
| Database Link | |
| Synonyms | BCL1; D11S287E; PRAD1; U21B31 | 
| Reference Data | |
| Protein Families | Druggable Genome, Stem cell - Pluripotency, Stem cell relevant signaling - DSL/Notch pathway, Stem cell relevant signaling - JAK/STAT signaling pathway, Stem cell relevant signaling - Wnt Signaling pathway | 
| Protein Pathways | Acute myeloid leukemia, Bladder cancer, Cell cycle, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, Focal adhesion, Glioma, Jak-STAT signaling pathway, Melanoma, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Pathways in cancer, Prostate cancer, Small cell lung cancer, Thyroid cancer, Viral myocarditis, Wnt signaling pathway | 
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
其它Cyclin D1产品
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        
 
	
 
                         
                             
                             
        